|
|
|
|
| LEADER |
03746nam a2200889Ia 4500 |
| 001 |
10.1002-npr2.12214 |
| 008 |
220427s2021 CNT 000 0 und d |
| 020 |
|
|
|a 2574173X (ISSN)
|
| 245 |
1 |
0 |
|a Suicide attempt induced by drug-induced leukoencephalopathy: A case report
|
| 260 |
|
0 |
|b John Wiley and Sons Inc
|c 2021
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1002/npr2.12214
|
| 520 |
3 |
|
|a Background: Leukoencephalopathy is identified during the administration of anticancer drugs. Symptoms vary from neurological symptoms to psychiatric symptoms depending on the site of damage. There have been no previous reports of suicide attempts due to drug-induced leukoencephalopathy. Case Presentation: The patient was diagnosed with diffuse large B-cell lymphoma (DLBCL) infiltrating the pharyngeal lesion. Rituximab + methotrexate + oncovin + procarbazine (R-MPV) therapy, a methotrexate-containing chemotherapy, was initiated. At the end of the fifth course, the patient attempted suicide by hanging with an appliance cord, which was associated with delusion. A head MRI scan showed no evidence of lymphoma recurrence, but white matter lesions around the ventricles showed progression. Conclusion: We report the case of a patient in whom drug-induced leukoencephalopathy related to methotrexate led to a suicide attempt. In addition to monitoring brain tumors, daily monitoring of psychiatric and neurological symptoms is important for patients with methotrexate-induced encephalopathy. © 2021 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology
|
| 650 |
0 |
4 |
|a aged
|
| 650 |
0 |
4 |
|a agitation
|
| 650 |
0 |
4 |
|a amnesia
|
| 650 |
0 |
4 |
|a antineoplastic agent
|
| 650 |
0 |
4 |
|a Antineoplastic Combined Chemotherapy Protocols
|
| 650 |
0 |
4 |
|a aphasia
|
| 650 |
0 |
4 |
|a Article
|
| 650 |
0 |
4 |
|a brain ischemia
|
| 650 |
0 |
4 |
|a brotizolam
|
| 650 |
0 |
4 |
|a cancer combination chemotherapy
|
| 650 |
0 |
4 |
|a cancer regression
|
| 650 |
0 |
4 |
|a case report
|
| 650 |
0 |
4 |
|a clinical article
|
| 650 |
0 |
4 |
|a cognitive defect
|
| 650 |
0 |
4 |
|a consciousness disorder
|
| 650 |
0 |
4 |
|a controlled study
|
| 650 |
0 |
4 |
|a delirium
|
| 650 |
0 |
4 |
|a delusion
|
| 650 |
0 |
4 |
|a diagnostic imaging
|
| 650 |
0 |
4 |
|a diffuse large B cell lymphoma
|
| 650 |
0 |
4 |
|a disease exacerbation
|
| 650 |
0 |
4 |
|a drug megadose
|
| 650 |
0 |
4 |
|a electrocardiogram
|
| 650 |
0 |
4 |
|a human
|
| 650 |
0 |
4 |
|a Humans
|
| 650 |
0 |
4 |
|a insomnia
|
| 650 |
0 |
4 |
|a Leukoencephalopathies
|
| 650 |
0 |
4 |
|a leukoencephalopathy
|
| 650 |
0 |
4 |
|a leukoencephalopathy
|
| 650 |
0 |
4 |
|a leukoencephalopathy
|
| 650 |
0 |
4 |
|a Magnetic Resonance Imaging
|
| 650 |
0 |
4 |
|a male
|
| 650 |
0 |
4 |
|a methotrexate
|
| 650 |
0 |
4 |
|a methotrexate
|
| 650 |
0 |
4 |
|a methotrexate
|
| 650 |
0 |
4 |
|a Methotrexate
|
| 650 |
0 |
4 |
|a Mini Mental State Examination
|
| 650 |
0 |
4 |
|a MRI
|
| 650 |
0 |
4 |
|a nose obstruction
|
| 650 |
0 |
4 |
|a nuclear magnetic resonance imaging
|
| 650 |
0 |
4 |
|a nursing home
|
| 650 |
0 |
4 |
|a paralysis
|
| 650 |
0 |
4 |
|a paranoia
|
| 650 |
0 |
4 |
|a perospirone
|
| 650 |
0 |
4 |
|a pharynx cancer
|
| 650 |
0 |
4 |
|a procarbazine
|
| 650 |
0 |
4 |
|a restlessness
|
| 650 |
0 |
4 |
|a rituximab
|
| 650 |
0 |
4 |
|a side effect
|
| 650 |
0 |
4 |
|a sinus rhythm
|
| 650 |
0 |
4 |
|a sore throat
|
| 650 |
0 |
4 |
|a suicide attempt
|
| 650 |
0 |
4 |
|a suicide attempt
|
| 650 |
0 |
4 |
|a suicide attempt
|
| 650 |
0 |
4 |
|a Suicide, Attempted
|
| 650 |
0 |
4 |
|a trazodone
|
| 650 |
0 |
4 |
|a vincristine sulfate
|
| 650 |
0 |
4 |
|a white matter lesion
|
| 700 |
1 |
|
|a Ichikawa, M.
|e author
|
| 700 |
1 |
|
|a Kawamata, Y.
|e author
|
| 700 |
1 |
|
|a Maehara, R.
|e author
|
| 700 |
1 |
|
|a Mitani, K.
|e author
|
| 700 |
1 |
|
|a Shimoda, K.
|e author
|
| 700 |
1 |
|
|a Yasui-Furukori, N.
|e author
|
| 773 |
|
|
|t Neuropsychopharmacology Reports
|
